Skip to content

MLI Pharma Engineering

Active Risk: very low
Limited partnershipfounded 2012active for 14 yearsBois du Foyau 88, 1440 Braine-le-Château, BelgiumKBO/BCE: BE 0845.815.848
Summary

MLI Pharma Engineering has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.2% (very low). No annual accounts have been filed with the National Bank.

MLI Pharma EngineeringActive

Register details

Identification
Legal formLimited partnership
Founded04-05-2012
Activities, NACEBEL 2025
46190Agents in non-specialised wholesale trade
70200Business and other management consultancy
71121Engineering and related technical consultancy, excluding land surveyors
71209Other technical testing and analysis
82990Other business support services
85599Other education
E-invoicing
Reachable via Peppol
Peppol ID 0208:0845815848
Also 9925:BE0845815848
Registered 11-11-2024

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 20 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Braine-le-Château · 1 establishment unit since 2012
registered office establishment The establishment unit on the map
Ground area
1,749 m²
Building footprint
134 m²
Building volume
769 m³
Parcel 25015B0322/00X000, Wallonia · tallest building 8.1 m. Linked by address, not a title deed.
2 companies at this address See who is registered here
1 establishment unit
Bois du Foyau 88, 1440 Braine-le-Château
Agents in non-specialised wholesale trade
since 2012unit no. 2.209.185.787
1 parcel
Wallonia 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
25015B0322/00X000 Wallonia 1,749 m² 1 · 134 m² 8.1 m · 2
How the parcels are linked
Good to know
The parcel matches the address exactly.